Back to Texas

HB2528 • 2025

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Bucy
Last action
2025-04-09
Official status
04/09/2025 H Left pending in committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

What This Bill Does

  • Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2025-04-09 Texas Legislature Online

    Scheduled for public hearing on . . .

  2. 2025-04-09 Texas Legislature Online

    Considered in public hearing

  3. 2025-04-09 Texas Legislature Online

    Testimony taken/registration(s) recorded in committee

  4. 2025-04-09 Texas Legislature Online

    Left pending in committee

  5. 2025-03-17 Texas Legislature Online

    Read first time

  6. 2025-03-17 Texas Legislature Online

    Referred to Insurance

  7. 2025-02-06 Texas Legislature Online

    Filed

Official Summary Text

Relating to health benefit plan coverage of prescription drugs for opioid and substance use disorders.

Current Bill Text

Read the full stored bill text
89(R) HB 2528 - Introduced version - Bill Text

By: Bucy

H.B. No. 2528

A BILL TO BE ENTITLED

AN ACT

relating to health benefit plan coverage of prescription drugs for

opioid and substance use disorders.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Chapter 1369, Insurance Code, is amended by

adding Subchapter E-3 to read as follows:

SUBCHAPTER E-3.

COVERAGE OF MEDICATION-ASSISTED TREATMENT

FOR OPIOID OR SUBSTANCE USE DISORDER

Sec.

1369.231.

DEFINITION. In this subchapter,

"medication-assisted opioid or substance use disorder treatment"

means the use of methadone, buprenorphine, buprenorphine/naloxone,

or naltrexone to treat opioid or substance use disorder.

Sec.

1369.232.

APPLICABILITY OF SUBCHAPTER. (a)

This

subchapter applies only to a health benefit plan that provides

benefits for medical or surgical expenses incurred as a result of a

health condition, accident, or sickness, including an individual,

group, blanket, or franchise insurance policy or insurance

agreement, a group hospital service contract, or an individual or

group evidence of coverage or similar coverage document that is

issued by:

(1) an insurance company;

(2)

a group hospital service corporation operating

under Chapter 842;

(3)

a health maintenance organization operating under

Chapter 843;

(4)

an approved nonprofit health corporation that

holds a certificate of authority under Chapter 844;

(5)

a multiple employer welfare arrangement that holds

a certificate of authority under Chapter 846;

(6)

a stipulated premium company operating under

Chapter 884;

(7)

a fraternal benefit society operating under

Chapter 885;

(8) a Lloyd's plan operating under Chapter 941; or

(9) an exchange operating under Chapter 942.

(b)

Notwithstanding any other law, this subchapter applies

to:

(1)

a small employer health benefit plan subject to

Chapter 1501, including coverage provided through a health group

cooperative under Subchapter B of that chapter;

(2)

a standard health benefit plan issued under

Chapter

1507;

(3)

nonprofit agricultural organization health

benefits offered by a nonprofit agricultural organization under

Chapter 1682;

(4)

alternative health benefit coverage offered by a

subsidiary of the Texas Mutual Insurance Company under Subchapter

M, Chapter 2054;

(5)

health benefits provided by or through a church

benefits board under Subchapter I, Chapter 22, Business

Organizations Code;

(6)

a regional or local health care program operated

under Section 75.104, Health and Safety Code; or

(7)

a self-funded health benefit plan sponsored by a

professional employer organization under Chapter 91, Labor Code.

(c)

This subchapter applies to coverage under a group health

benefit plan provided to a resident of this state regardless of

whether the group policy, agreement, or contract is delivered,

issued for delivery, or renewed in this state.

Sec.

1369.233.

EXCEPTIONS TO APPLICABILITY OF SUBCHAPTER.

This subchapter does not apply to an issuer or provider of health

benefits under or a pharmacy benefit manager administering pharmacy

benefits under:

(1)

the state Medicaid program, including the Medicaid

managed care program under Chapter 533, Government Code; or

(2)

the child health plan program under Chapter 62,

Health and Safety Code.

Sec.

1369.234.

LIMITATIONS ON PRIOR AUTHORIZATION. A

health benefit plan that provides coverage for medication-assisted

opioid or substance use disorder treatment may not require an

enrollee to obtain prior authorization for the treatment, except as

needed to minimize the opportunity for fraud, waste, and abuse.

SECTION 2. This Act applies only to a health benefit plan

delivered, issued for delivery, or renewed on or after January 1,

2026. A health benefit plan delivered, issued for delivery, or

renewed before January 1, 2026, is governed by the law as it existed

immediately before the effective date of this Act, and that law is

continued in effect for that purpose.

SECTION 3. This Act takes effect September 1, 2025.